Efficacy of Valproic Acid Against Coronavirus Disease 2019 Infection or Severity: A Pilot Study
Conclusions
In this pilot study, no support was found for the hypothesis of a protective effect of VPA against the infectivity rate of COVID-19. Neither was there any indication of a disease-modulating effect of VPA in people with active COVID-19 infection. Larger, randomized controlled trials would be warranted to substantiate our conclusion.
Source: Clinical Neuropharmacology - Category: Neurology Tags: Original Articles Source Type: research
More News: Brain | Coronavirus | COVID-19 | Databases & Libraries | Epilepsy | Intensive Care | Neurology | Pandemics | Study